[1] Jones K E, Patel N G, Levy M A, et al. Global trends in emerging infectious diseases[J].Nature,2007(451):990-993.
[2] 吕媛,李耘,郑波.国内外细菌耐药监测研究介绍[J].中国临床药理学杂志,2011(4):311-317.
[3] US Food and Drug and Administration. Class II special controls guidance document: antimicrobial susceptibility test (AST) systems; guidance for industry and FDA[R].Rockville, MD: US Food and Drug Administration,2003.
[4] 陈民钧.临床细菌学的重要任务——药敏检测[J].中华医学检验杂志,1993(16):325-327.
[5] 李庆福.解决滥用药物的方法——药敏试验[J].畜牧兽医科技信息,2009(3):121.
[6] 王辉,胨民钧.药敏试验的方法学进展[J].中华医学检验杂志, 1997(20):342-344.
[7] Wheat P F. History and development of antimicrobial susceptibility testing methodology[J].Journal of Antimicrobial Chemotherapy,2001,48(1):1-4.
[8] 王金良.我国药敏试验标准化的进程与展望[J].中华检验医学杂志,2006,29(1):14-16.
[9] Qi C, Stratton C W, Zheng X T. Phenotypic testing of bactierial antimicrobial susceptibility[J].Advaced technique in diagnostic microbiology,2006,1:63-68.
[10] 魏殿军.抗生素体外药敏试验新进展及临床意义[J].四川生理科学杂志,1998(20):19-22.
[11] 肖履中.对制片扩散法药敏试验的再认识[J].上海畜牧兽医通讯, 2000(2):34-35.
[12] 刘山辉.抗菌药物的药敏试验方法[J].吉林畜牧兽医,2003:12.
[13] 金少鸿,马越.亚太地区细菌耐药性监测现状和展望[J].中国药物应用与监测,2006(3):1-3.
[14] Korgenski E K, Daly J A. Evaluation of the BIOMIC video reader for determining interpretive categories of isolates on the basis of disk diffusion susceptibility results[J].Journal of Clinical Microbiology,1998(36):302-304.
[15] Nijs A, Cartuyvels R, Mewis A, et al. Comparison and evaluation of Osiris and Sirscan 2000 antimicrobial susceptibility systems in the clinical microbiology laboratory [J]. Journal of Clinical Microbiology, 2003(41):3627-3630.
[16] 马纪平.要正确评价和应用稀释法和扩散法细菌药敏试验[J].中华医学检验杂志,1998(21):251.
[17] Murray P R, Baron E J, Jorgensen J H, et al. Manual of clinical microbiology 9th edition[M]. Washington, DC: American Society for Microbiology press,2007:1152-1172.
[18] Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility testing for bacteria that grew aerobically (Approved Standard M7 – A10) [S].Wayne, PA: Clinical and Laboratory Standards Institute,2009.
[19] Jorgensen J H, Ferraro M J. Antimicrobial susceptibility testing: a review of general principles and contemporary practices[J]. Clinical Infectious Diseases,2009,49(11):1749-1755.
[20] Huang M B, Baker C N, Banerjee S, et al. Accuracy of the Etest for determining antimicrobial susceptibilities of Staphylococci enterococci, Campylobacter jejuni and gram-negative bacteria resistant to antimicrobial agents[J].Journal of Clinical Microbiology,1992(30):3243-3248.
[21] 毛家都.药敏检测方法新进展-Etest 法学术研讨会纪要[J].中华医学检验杂志,1997(20):316-317.
[22] Najafzadeh M J, Falahati M, Pooshanga B K, et al. Flow cytometry susceptibility testing for conventional antifungal drugs and comparison with the NCCLS Broth Macrodilution Test[J].DARU,2009(17):94-98.
[23] 张明霞,梅国华,熊顺景,等.应用流式细胞术检测结核分支杆菌药敏试验[J].中国临床保健杂志,2009(15):616-618.
[24] Raman R, Chaturvedi V. Flow cytometry antifungal susceptibility testing of pathogenic yeasts other than Candida albicans and comparison with the NCCLS broth microdilution test[J].Antimicrobial agent and chemotherapy,2000(44): 2752-2758.
[25] Rudensky B, Broidie E, Yinnon A M, et al. Rapid flow-cytometric susceptibility testing of Candida species[J]. Journal of Antimicrobial Chemotherapy,2005(55):106-109.
[26] Wenisch C, Linnau K F, Parschalk B, et al. Rapid susceptibility testing of Fugi by flow cytometry using vital staining[J]. Journal of clinical microbiology,1997(35):5-10.
[27] Chen C H, Lu Y, Sin M L Y, et al. Antimicrobial susceptibility testing using high surface-to-volume ratio microchannels[J]. Journal of analytical chemistry,2010(82):1012-1019.
[28] Amorena B, Gracia E, Monzón M, et al. Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro[J].Journal of antimicrobial chemotherapy, 1999(44):43-55.
[29] Clutterbuck A L, Cochrane C A, Dolman J, et al. Evaluating antibiotics for use in medicine using a poloxamer biofilm model [J].Annals of Clinical Microbiology and Antimicrobials,2007(6): 2.
[30] Collins L A, Franzblau S G. Microplate anlamar blue assay versus BACTEC 460 system for high throughput screening of compounds against mycobacterium tuberculosis and mycobacterium avium[J]. Antimicrobial agents chemother,1997, 41(5):1004-1009.
[31] 郭以河,张闽峰,孟家榕.MTT 法体外药敏试验研究进展及临床应用[J].东南国防医药,2005(7):77-78.
[32] 俞诗娃,许晨耘,柯雅娟,等.应用三磷酸腺苷生物荧光法对手术体位垫表面细菌含量快速检测[J].中国消毒学杂志,2010(27): 271-272.
[33] 樊慧珍,于化鹏,黄文杰,等.探针杂交法快速检测耐甲氧西林葡萄球菌[J].中华结核呼吸杂志,2005(8):557-558.
[34] Louie L, Goodfellow J, Mathieu P, et al. Rapid detection of methicillin-resistant staphylococci from blood culture bottles by using a multiplex PCR assay[J].Journal of clinical microbiology,2002,40(8):2786-2790.
[35] McKessar S J, Berry A M, Bell J M, et al. Genetic characterization of vanG, a novel vancomycin resistance locus of Enterococcus faecalis[J].Antimicrob agents chemother,2000, 44(11):3224-3228.
[36] Tenover F C. DNA probes for antimicrobial susceptibility testing[J].Journal of laboratory and clinical medicine,1989(9): 341-347.
[37] Clinical and Laboratory Standards Institute. Development of in vitro susceptibility testing criteria and quality control parameters; approved guideline (3rd editon, CLSI document M23 – A3) [S].Wayne, PA: Clinical and Laboratory Standards Institute, 2008.
[38] MacGowan A P, Wise R. Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests[J].Journal of Antimicrobial Chemotherapy, 2001,48(l):17-28.
[39] 陈鸿波, 马越. 药敏判断标准新动向 [J]. 中国药房,2006(17): 1754-1755.
[40] Barenfanger J, Drake C, Kacich G. Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing[J].Journal of Clinical Microbiology,1999 (37):1415-1418.
|